Medication can be part of alcohol treatment in London, but the right discussion starts with its purpose. Managing withdrawal, supporting a longer-term change in drinking, and treating nutritional deficiency are different tasks. A medication suitable for one task may do nothing for another. The prescribing decision also depends on physical health, other medicines, previous treatment, and the person’s goals.
This guide explains the main conversations to have with a clinician rather than providing a regimen to start yourself. For the broader assessment and care pathway, see alcohol use disorder treatment in London. A prescription should connect to an agreed plan for monitoring, support, and access to advice when circumstances change.
First establish whether withdrawal needs medical management
Someone who becomes shaky, sweaty, nauseated, or unwell when alcohol wears off may need assessment for physical dependence. The NHS alcohol use disorder guidance warns that suddenly stopping can be harmful when a person is dependent. Severe withdrawal symptoms, including seizures, hallucinations, or marked confusion, need urgent medical help.
A clinician may use a short course of medication within medically assisted withdrawal. That involves an assessment of where treatment can safely happen and how symptoms will be monitored. It is a different decision from choosing a medicine intended to support recovery over subsequent months. Our London alcohol detox guide explains the setting question in more detail.
When contacting a service, describe what happens between drinks, previous withdrawal complications, and all substances or medicines being taken. Asking only for an “anti-craving tablet” may leave the immediate problem unclear. Tell the clinician if you have already cut down sharply or stopped, rather than waiting for a routine medication appointment while becoming increasingly unwell.
Acamprosate: support for maintaining an alcohol-free period
Acamprosate is used to help people maintain abstinence from alcohol. Royal Free London’s patient information describes its role in reducing the desire to drink alongside counseling. It does not protect the body from the harmful effects of continued drinking, and it should not be mistaken for medication that makes an unsafe withdrawal manageable at home.
Practical fit matters. The prescribed schedule involves taking tablets at different points in the day. Someone who works unpredictable shifts could ask a pharmacist how to incorporate their actual prescription into that routine. That discussion should cover the instructions for forgotten doses rather than relying on an improvised catch-up approach.
Gastrointestinal symptoms such as diarrhea or nausea can occur. Report troublesome symptoms, including whether they interfere with eating or taking the medicine. The BNF acamprosate monograph also identifies kidney function as an important prescribing consideration. An online description of a medicine as suitable for alcohol recovery does not establish that it is suitable for an individual.
A useful question is: “What improvement would make this worth continuing for me?” The answer could connect drinking goals with cravings, day-to-day function, and tolerability. A review is more informative when those expectations are recorded at the start, especially if several other parts of treatment begin at the same time.
Naltrexone: alcohol treatment with important opioid implications
Naltrexone blocks opioid receptors and can reduce alcohol’s rewarding effects. Royal Free London’s naltrexone leaflet explains its use in supporting alcohol abstinence. Possible adverse effects include nausea, headache, dizziness, and stomach discomfort. A prescriber should explain which changes to report and how to get advice between appointments.
Its opioid-blocking action makes a complete medication history essential. This includes prescribed painkillers, nonprescribed opioids, and some pharmacy products. Starting naltrexone when opioids remain relevant to the person’s treatment or dependence can create serious problems, including precipitated withdrawal. Do not use a generic online waiting period to decide when it is safe to start.
It also changes the conversation about pain relief. Tell clinicians that you take naltrexone before a procedure or emergency treatment. If surgery is planned, ask the alcohol prescriber and surgical team to communicate in advance. Do not attempt to overcome the blocking effect by taking more opioid medication yourself.
A person using codeine for recurring pain, for example, needs that issue resolved within the prescribing discussion. They should not be left choosing between untreated pain and stopping an alcohol medicine without advice. The appointment should produce a coordinated plan, with a named clinician responsible for decisions when either condition changes.
Disulfiram: an alcohol reaction requires informed agreement
Disulfiram works differently. It interferes with the breakdown of alcohol and can cause a dangerous reaction if alcohol is consumed. Royal Free London’s disulfiram guidance explains that the reaction can be severe or life-threatening. This is a deterrent-based treatment, not a tablet that simply removes cravings.
The discussion must include alcohol in products as well as drinks, relevant interactions, and the period of risk after stopping the medicine. A clinician or pharmacist should explain the actual product instructions. Severe symptoms after alcohol exposure require urgent medical help; deliberately testing whether the medication is working is unsafe.
If a relative helps someone take a prescribed medicine, the arrangement should be discussed openly and agreed with the patient and clinical team. Disulfiram should never be secretly added to food or drink. A family member’s understandable wish to prevent drinking is not a substitute for the person’s informed participation in treatment.
Ask how the service evaluates medical suitability, including liver health, and how monitoring is organized. Also discuss what happens if the patient changes their goal or does not want to continue. The plan needs a route back to professional advice rather than an escalating conflict at home about whether a tablet has been taken.
Nalmefene has a particular reduction-focused indication
NICE’s nalmefene recommendation concerns selected adults with alcohol dependence who continue to have a high drinking risk level, do not have physical withdrawal symptoms, and do not need immediate detoxification. It is used with ongoing psychosocial support. The recommendation does not make it a general replacement for assessing dependence or withdrawal risk.
Someone seeking to reduce drinking can ask whether this option fits their circumstances and what alternatives are appropriate. The fact that their preferred goal is reduction does not itself settle the medication choice. Conversely, discussing reduction honestly is more useful than claiming an abstinence goal solely to gain access to an appointment.
Why thiamine may appear on the same treatment plan
Thiamine is vitamin B1. Its role is to prevent or treat deficiency, not to remove cravings. The NHS Specialist Pharmacy Service guidance explains that alcohol dependence can require assessment for thiamine deficiency and its neurological consequences. The clinician determines the appropriate preparation and route from the clinical situation.
It helps to ask the purpose of every item on a discharge or treatment list. A person may otherwise assume that receiving vitamins means they have received all necessary alcohol treatment, or that several prescriptions are interchangeable. Nutrition, withdrawal care, and ongoing recovery support can each need attention within the same episode of care.
Accessing medication through a London service
Start with a GP or the appropriate local alcohol service. As a concrete example, Tower Hamlets RESET lists access to alcohol relapse prevention medication, community alcohol detox, and regular prescribing reviews within its services. It also describes access to inpatient detox and residential rehabilitation, which should not be read as inpatient accommodation at a community hub.
Eligibility and prescribing arrangements differ between boroughs. Give the service your home borough, GP details, and current treatment arrangements. If a referral is redirected, ask which team is responsible for the next step and how medication questions will be handled meanwhile. A central London consultation address does not automatically provide access to another borough’s commissioned care.
The UK clinical guidelines for alcohol treatment place relapse prevention medication within a psychosocial treatment and recovery plan. They also explain that lack of access to complex specialist psychological therapy should not itself prevent access to medication. Discuss what support is available now, including regular contact, rather than assuming every element must start simultaneously.
Make the review specific enough to guide a decision
Bring a short record of the prescribed medication, actual use, benefits, unwanted effects, and changes in drinking. Include new medicines, pregnancy or pregnancy plans, hospital visits, and significant changes in physical or mental health. The aim is an accurate account that helps the clinician judge treatment, not a perfect report created to avoid disappointing them.
Ask who issues the next prescription, who checks any blood results, and when treatment will be reviewed. If prescribing is moving from a specialist to a GP, confirm that the handover has been accepted. The GMC’s shared care guidance emphasizes agreement and clarity about responsibilities between the professionals and patient.
Medication choices can change as circumstances become clearer. A return to drinking, an intolerable adverse effect, or an upcoming operation is information to bring back to the prescriber. Alongside that review, relapse prevention therapy can help examine the situations in which drinking resumes and develop practical responses. Neither part of care should remain isolated from the other.
Leave the appointment able to explain the plan in ordinary language: what this medicine is intended to help, how it will be monitored, what support accompanies it, and whom to contact if there is a problem. If those points remain unclear, request clarification before relying on assumptions about the next prescription or follow-up visit.